Subanesthetic Ketamine Infusion Therapy: A Retrospective Analysis of a Novel Therapeutic Approach to Complex Regional Pain Syndrome
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
UNLABELLED: Complex Regional Pain Syndrome (CRPS) is a disorder that can be accompanied by severe pain that is often both chronic and resistant to conventional therapy. Harbut and Correll previously reported the successful treatment of a 9-year case of intractable Type I CRPS with an intravenous inpatient infusion of ketamine in an adult female patient. OBJECTIVE: The purpose of this study was to ascertain if indeed the use of subanesthetic inpatient infusions of ketamine provide meaningful improvements in pain scores, and thus, quality of life, in patients suffering from CRPS. To achieve this objective we focused our analysis on the relief of pain obtained by patients undergoing this novel treatment option developed at Mackay Base Hospital, Queensland, Australia. METHODS: Case notes of 33 patients whose CRPS pain was treated by the inpatient administration of a continuous subanesthetic intravenous infusion of ketamine were reviewed. The dose and duration of ketamine therapy and the degree and duration of relief obtained were recorded. Notable side effects were also recorded. The degree of relief obtained (immediately after the infusion) was assessed using pre- and posttreatment numeric pain scores. The duration of relief obtained (throughout the follow-up period) was analyzed using a Kaplan-Meier cumulative survival curve analysis. RESULTS: A total of 33 patients with diagnoses of CRPS who had undergone ketamine treatment at least once were identified. Due to relapse, 12 of 33 patients received a second course of therapy, and two of 33 patients received a third. The degree of relief obtained following the initial course of therapy was impressive (N=33); there was complete pain relief in 25 (76%), partial relief in six (18%), and no relief in two (6%) patients. The degree of relief obtained following repeat therapy (N=12) appeared even better, as all 12 patients who received second courses of treatment experienced complete relief of their CRPS pain. The duration of relief was also impressive, as was the difference between the duration of relief obtained after the first and after the second courses of therapy. In this respect, following the first course of therapy, 54% of 33 individuals remained pain free for >/=3 months and 31% remained pain free for >/=6 months. After the second infusion, 58% of 12 patients experienced relief for >/=1 year, while almost 33% remained pain free for >3 years. The most frequent side effect observed in patients receiving this treatment was a feeling of inebriation. Hallucinations occurred in six patients. Less frequent side effects also included complaints of lightheadedness, dizziness, and nausea. In four patients, an alteration in hepatic enzyme profile was noted; the infusion was terminated and the abnormality resolved thereafter. CONCLUSION: This retrospective review suggests that limited subanesthetic inpatient infusions of ketamine may offer a promising therapeutic option in the treatment of appropriately selected patients with intractable CRPS. More study is needed to further establish the safety and efficacy of this novel approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Woolf, C. J., & Thompson, S. W. N. (1991) · Pain · doi:10.1016/0304-3959(91)90100-c · Cited by 1,963
Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs
Olney, J. W., Labruyere, J., & Price, M. T. (1989) · Science · doi:10.1126/science.2660263 · Cited by 1,237
Physiological properties of unmyelinated fiber projection to the spinal cord
Mendell, L. M. (1966) · Experimental Neurology · doi:10.1016/0014-4886(66)90068-9 · Cited by 845
NMDA Antagonist Neurotoxicity: Mechanism and Prevention
Olney, J. W., Labruyere, J., Wang, G., Wozniak, D. F., Price, M. T., & Sesma, M. A. (1991) · Science · doi:10.1126/science.1835799 · Cited by 841
Malhotra, M. D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00036-5 · Cited by 680
Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis
Newcomer, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00067-0 · Cited by 604
Eide, P. K., Jørum, E., Stubhaug, A., Bremnes, J., & Breivik, H. (1994) · Pain · doi:10.1016/0304-3959(94)90129-5 · Cited by 490
Nelson, K. A., Park, K. M., Robinovitz, E., Tsigos, C., & Max, M. B. (1997) · Neurology · doi:10.1212/wnl.48.5.1212 · Cited by 357
Nikolajsen, L., Hansen, C. L., Nielsen, J., Keller, J., Arendt-Nielsen, L., & Jensen, T. S. (1996) · Pain · doi:10.1016/0304-3959(96)03080-1 · Cited by 352
Response of chronic neuropathic pain syndromes to ketamine: a preliminary study
Backonja, M., Arndt, G., Gombar, K. A., Check, B., & Zimmermann, M. (1994) · Pain · doi:10.1016/0304-3959(94)90149-x · Cited by 312
Smith, M. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03290.x · Cited by 293
Update on the Neurophysiology of Pain Transmission and Modulation
Bennett, G. J. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00120-7 · Cited by 270
Targeting the N-Methyl-d-Aspartate Receptor for Chronic Pain Management
Fisher, K., Coderre, T. J., & Hagen, N. A. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00213-x · Cited by 266
Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord
Aanonsen, L. M., Lei, S., & Wilcox, G. L. (1990) · Pain · doi:10.1016/0304-3959(90)90008-2 · Cited by 252
Levanen, J., Makela, M.-L., & Scheinin, H. (1995) · Anesthesiology · doi:10.1097/00000542-199505000-00005 · Cited by 189
Pain Mechanisms and Management: A Central Perspective
Mannion, R. J., & Woolf, C. J. (2000) · The Clinical Journal of Pain · doi:10.1097/00002508-200009001-00006 · Cited by 175
A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide
Jevtovic-Todorovic, V., Wozniak, D. F., Benshoff, N. D., & Olney, J. W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02079-0 · Cited by 163
LaBella, F. S., Pinsky, C., & Havlicek, V. (1979) · Brain Research · doi:10.1016/0006-8993(79)90849-7 · Cited by 151
NMDA-Receptor Antagonists in Neuropathic Pain
Sang, C. N.-M. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00125-6 · Cited by 143
Wright, A. W. E., Mather, L. E., & Smith, M. T. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01133-x · Cited by 135
Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity
Farber, N. B., Kim, S. H., Dikranian, K. T., Jiang, X. P., & Heinkel, C. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000912 · Cited by 133
Reflex sympathetic dystrophy : a reappraisal
Jänig, W., & Stanton-Hicks, M. D. (1996) · Medical Entomology and Zoology · Cited by 129
Multifocal brain damage induced by phencyclidine is augmented by pilocarpine
Corso, T. D., Sesma, M. A., Tenkova, T. I., Der, T. C., Wozniak, D. F., Farber, N. B., & Olney, J. W. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01347-9 · Cited by 107
Bartlett, S. E., Cramond, T., & Smith, M. T. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00552-4 · Cited by 106
Snider, B. S., Asmundson, G. J. G., & Wiese, K. C. (2000) · The Clinical Journal of Pain · doi:10.1097/00002508-200006000-00008 · Cited by 100
Competitive and noncompetitive NMDA antagonists induce similar limbic degeneration
Ellison, G. (1994) · NeuroReport · doi:10.1097/00001756-199412000-00070 · Cited by 94
Kim, S. H., Price, M. T., Olney, J. W., & Farber, N. B. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000529 · Cited by 86
Oral ketamine therapy in the treatment of postamputation stump pain
NIKOLAJSEN, L., HANSEN, P. O., & JENSEN, T. S. (1997) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1997.tb04710.x · Cited by 78
Lee, Y.-W., & Yaksh, T. L. (1995) · Anesthesiology · doi:10.1097/00000542-199503000-00016 · Cited by 75
Hemstapat, R., Monteith, G. R., Smith, D. L., & Smith, A. M. T. (2003) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000059225.40049.99 · Cited by 73
Successful Treatment of Postherpetic Neuralgia with Oral Ketamine
Hoffmann, V. L. H., Coppejans, H. C., Vercauteren, M. P., & Adriaensen, H. A. (1994) · Clinical Journal of Pain · doi:10.1097/00002508-199409000-00011 · Cited by 69
Klepstad, P., & Borchgrevink, P. C. (1997) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1997.tb04709.x · Cited by 66
(1998) · Receptor - Based Drug Design · doi:10.1201/9781420001136-33 · Cited by 63
Post‐operative pain relief with ketamine infusion
Ito, Y., & Ichiyanagi, K. (1974) · Anaesthesia · doi:10.1111/j.1365-2044.1974.tb00626.x · Cited by 59
Activation of N-Methyl-d-Aspartate Receptor Attenuates Acute Responsiveness of δ-Opioid Receptors
Cai, Y.-C., Ma, L., Fan, G.-H., Zhao, J., Jiang, L., & Pei, G. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.4.583 · Cited by 59
Jevtović‐Todorović, V., Wozniak, D. F., Powell, S., Nardi, A. M. D., & Olney, J. W. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01247-x · Cited by 54
α2 Adrenergic Agonists Prevent MK-801 Neurotoxicity
Farber, N. B., Foster, J., Duhan, N. L., & Olney, J. W. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00048-i · Cited by 51
Handa, F., Tanaka, M., Nishikawa, T., & Toyooka, H. (2000) · Journal of Clinical Anesthesia · doi:10.1016/s0952-8180(99)00131-2 · Cited by 50
Pandit, S. K., Kothary, S. P., & Kumar, S. M. (1980) · Anaesthesia · doi:10.1111/j.1365-2044.1980.tb03882.x · Cited by 41
Morphine-3β-d-glucuronide Suppresses Inhibitory Synaptic Transmission in Rat Substantia Gelatinosa
Moran, T. D., & Smith, P. A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035626 · Cited by 38
Harbut, R. E., & Correll, G. E. (2002) · Pain Medicine · doi:10.1046/j.1526-4637.2002.02029.x · Cited by 35
Self-citationMorphine Tolerance Decreases the Analgesic Effects of Ketamine in Mice
Finck, A. D., Samaniego, E., & Ngai, S. H. (1988) · Anesthesiology · doi:10.1097/00000542-198803000-00013 · Cited by 26
150 years of Sigmund Freud: what would Freud have said about the obesity epidemic?
Bornstein, S. R., Wong, M., & Licinio, J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001912 · Cited by 23
NMDA Receptors and Pain—Hopes for Novel Analgesics
Carpenter, K. J., & Dickenson, A. H. (1999) · Regional Anesthesia & Pain Medicine · doi:10.1016/s1098-7339(99)90039-1 · Cited by 18
Cited by
Morgan, C. J. A., Curran, H. V., & the Independent Scientific Committee on Drugs (ISCD) (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03576.x · Cited by 667
Schwenk, E. S., Viscusi, E. R., Buvanendran, A., Hurley, R. W., Wasan, A. D., Narouze, S., Bhatia, A., Davis, F. N., Hooten, W. M., & Cohen, S. P. (2018) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000806 · Cited by 584
Sigtermans, M. J., van Hilten, J. J., Bauer, M. C. R., Arbous, S. M., Marinus, J., Sarton, E. Y., & Dahan, A. (2009) · Pain · doi:10.1016/j.pain.2009.06.023 · Cited by 467
Ketamine: 50 Years of Modulating the Mind
Li, L., & Vlisides, P. E. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00612 · Cited by 385
Role of central dopamine in pain and analgesia
Wood, P. B. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.781 · Cited by 370
Metadata
- Authors
- Correll, G. E., Maleki, J., Gracely, E. J., Muir, J. J., & Harbut, R. E.
- Venue
- Pain Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-09
- Volume
- 5
- Issue
- 3
- Pages
- 263-275
- ISSN
- 1526-2375 (ISSN-L)
- 1526-4637
- OpenAlex
- W2145977703
- Cited by
- 271
- References
- 45
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.